21
Participants
Start Date
April 23, 2020
Primary Completion Date
November 2, 2020
Study Completion Date
November 10, 2023
Camrelizumab
Inductive therapy with Camrelizumab of 200mg, iv, qd, on day 1, 15, 29.
Apatinib
Inductive therapy with Apatinib of 250mg, po, qd, initiating on day 1, ending on the fifth day before surgery.
Radical surgery
Radical surgery will be performed on the 42th-45th after initiation of inductive therapy
Post-operative radiotherapy/chemoradiotherapy
Post-operative radiotherapy/chemoradiotherapy will be performed within 1.5 months after radical surgery, depending on the post-operative pathologic diagnosis.
Shanghai Ninth People's Hospital, Shanghai
Shanghai Jiao Tong University School of Medicine
OTHER